×

CSL: Seeing strong operational performance

6:31 PM ET Tue, 11 Feb 2014

After blood products maker CSL posted a 3 percent rise in first-half profit, Paul Perreault, MD and CEO, explains why he expects a 7 percent increase for full-year earnings.